U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Over-the-Counter (OTC) Drugs
  6. Status of OTC Rulemakings
  7. Rulemaking History for OTC Anorectal Drug Products
  1. Status of OTC Rulemakings

Rulemaking History for OTC Anorectal Drug Products

  

Final Monograph (21 CFR part 346):
Anorectal Drug Products for Over-the-Counter Human Use

 

OTC Anorectal Drug Products found on this page:

Anorectol Drug Products: Original Active Ingredients & Labeling

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice of Proposed Rulemaking [PDF]5/27/198045FR35576disclaimer icon
    Correction [PDF]7/22/198045FR48920disclaimer icon
    Correction [PDF]8/15/198045FR54354disclaimer icon
Reopening of Administrative Record: Camphor-containing products [PDF]9/26/198045FR63876disclaimer icon
Proposed RuleDateFR Citation
Tentative Final Monograph [PDF]8/15/198853FR30756disclaimer icon
Final RuleDateFR Citation
Final Monograph [PDF]8/3/199055FR31776disclaimer icon
    Technical Amendment: Live yeast cell derivative (LYCD) [PDF]9/2/199358FR46746disclaimer icon
    Technical Amendment: USP name change ("Hamamelis water" to "witch hazel") [PDF]6/3/199459FR28766
    Technical Amendment: Combination of hydrocortisone and pramoxine hydrochloride is nonmonograph [PDF]8/26/200368FR51167

Anorectal Drug Products: Sodium Labeling

Proposed RuleDateFR Citation
Proposed Rule: Sodium phosphate-containing products [PDF]3/24/200469FR13765
Final RuleDateFR Citation
Final Rule [PDF]11/29/200469FR69278